A novel biparametric magnetic resonance imaging sequence provides a more efficient and similarly efficacious method of risk stratifying men clinically suspected of having prostate cancer

Magnetic resonance imaging (MRI) for men suspected of having prostate cancer has become the standard of care. This is supported by the publication of high-quality data that it reduces the need for prostate biopsy and the diagnosis of clinically insignificant cancers, while increasing the diagnosis of clinically significant cancers (1-3).